| Execution period | 36 months |
|---|
BSE filing, BSE: 544310. Summary written from the filing by ALFA Finder's alert engine.
Yash Highvoltage Ltd: key numbers
- Share price
- ₹1,270.00
- Market cap
- ₹3,797 Cr
- Revenue (annual)
- ₹235.2 Cr
- Net profit (annual)
- ₹37.32 Cr
- P/E (TTM)
- 101.7×Sector 51.9×
- Promoter holding
- 53.79%
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yash Highvoltage Ltd
All →Yash Highvoltage Earnings Call Transcript: Key Takeaways
Yash Highvoltage delivers explosive 95% YoY revenue growth, driven by domestic infrastructure demand and pricing power.
- Call
- Guides 414% growth
Yash Highvoltage Other Announcement
Yash Highvoltage Limited submitted its quarterly Statement of Deviation or Variation in utilization of funds raised through a preferential issue as required under SEBI regulations.
Yash Highvoltage Employee Stock Options
Yash Highvoltage Limited has allotted 9,200 equity shares following the exercise of vested employee stock options under its ESOP Scheme 2025.
Yash Highvoltage Results Update
Yash Highvoltage's H1 FY27 revenue grew 95% YoY to ₹194.5 crore, with EBITDA rising to ₹54.7 crore and PAT to ₹36.2 crore.
Yash Highvoltage Investor Presentation: Key Takeaways
Yash Highvoltage reported strong H1FY27 performance with revenue growth of 95% YoY. Management highlights international expansion, specifically in the US, and upcoming commissioning of a new greenfield facility for backward integration.
- Call
- Guides 300% growth
Yash Highvoltage H1 FY27 Results: Net Profit ₹36.4 Cr, Up 165.7% QoQ
Yash Highvoltage Ltd reported revenue from operations of ₹194.5 Cr and net profit of ₹36.4 Cr for H1 FY27.
- Key figure
- Net profit ₹36.4 Cr
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.